CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid TestWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D003141 Communicable Diseases NIH 0.12
D007239 Infection NIH 0.08

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Use of the ANTIBODY BASED LATERAL FLOW IMMUNOASSAY TESTS FOR SARSCoV-2 THAT CAUSES CORONAVIRUS DISEASE 2019 (COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings

This study will be conducted as a registry to identify asymptomatic or symptomatic persons to determine whether they carry SARS-CoV-2 antibodies.

NCT04352764 Covid19 Diagnostic Test: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test

Primary Outcomes

Description: To evaluate the prevalence of COVID-19 exposure to healthcare staff, community 1st responders and patients. and patient population within a subspecialty

Measure: prevalence of COVID-19 exposure

Time: Mar-Dec 2020

Secondary Outcomes

Description: correlation between the test results with the presence or lack of COVID-19 symptoms or illness

Measure: correlation between the test results with the presence or lack of COVID-19 symptoms or illness

Time: Mar-Dec 2020

Description: correlate pre-existing risk factors with test results and baseline symptoms

Measure: correlate pre-existing risk factors with test results and baseline symptoms

Time: Mar-Dec 2020

Description: correlate subsequent healthcare utilization with test results and baseline symptoms

Measure: correlate subsequent healthcare utilization with test results and baseline symptoms

Time: Mar-Dec 2020


No related HPO nodes (Using clinical trials)